Company: CI
Filing Date: 2025-07-31
Form Type: 10-Q
Source: 0001739940-25-000028
Chunk: 282

Company: Cigna Group
Filing Date: 2025-07-31
Form: 10-Q
Item: Part II, Item 3
Chunk 282
---
:(In millions)December 31, 2024Cash and cash equivalents$1,339 Investments1,444 Accounts receivable, net1,927 Other assets, including Goodwill (1)2,294 Total assets of businesses held for sale7,004 Insurance and contractholder liabilities1,579 All other liabilities831 Total liabilities of businesses held for sale$2,410 (1) Includes Goodwill of $94 million.

Integration and Transaction-Related CostsIn 2025 and 2024, the Company incurred transaction-related costs associated with the HCSC transaction. These costs incurred consisted primarily of certain projects to separate the Company's systems, products and services; fees for legal, advisory and other professional services; and certain employment-related costs. These costs were $74 million pre-tax ($56 million after-tax) for the three months ended and $290 million pre-tax ($220 million after-tax) for the six months ended June 30, 2025, compared with $63 million pre-tax ($47 million after-tax) for the three months ended and $100 million pre-tax ($76 million after-tax) for the six months ended June 30, 2024.

Note 6 – Earnings Per Share

Basic and diluted earnings per share were computed as follows:

Three Months EndedJune 30, 2025June 30, 2024(Shares in thousands, dollars in millions, except per share amounts)BasicEffect ofDilutionDilutedBasicEffect ofDilutionDilutedShareholders' net income$1,532 $1,532 $1,548 $1,548 Shares:Weighted average266,181 266,181 281,133 281,133 Common stock equivalents1,973 1,973 2,919 2,919 Total shares266,181 1,973 268,154 281,133 2,919 284,052 Earnings per share$5.76 $(0.05)$5.71 $5.51 $(0.06)$5.45 

12

Six Months EndedJune 30, 2025June 30, 2024(Shares in thousands, dollars in millions, except per share amounts)BasicEffect ofDilutionDilutedBasicEffect ofDilutionDilutedShareholders' net income$2,855 $2,855 $1,271 $